Correction to: The CEPH aging cohort and biobank: a valuable collection of biological samples from exceptionally long‑lived French individuals and their offspring for longevity studies

Correction to: GeroScience

10.1007/s11357-023-01037-4

The original version of this article contained a few errors introduced during the typesetting process.

There were errors in the brackets used to delimit age intervals in the abstract and Table 2. We have corrected the age intervals to avoid any confusion.

“semi-supercentenarians ([105–110] years old)” has been corrected to “semi-supercentenarians ([105–109] years old)” in the Abstract.

“[90–100]; nonagenarians”, “[100–105]”, and “[105–110]; semi-supercentenarians” have been corrected to “[90–99]; nonagenarians”, “[100–104]”, and “[105–109]; semi-supercentenarians” in Table 2, respectively. 

New Table 2:

Table 2.

Demographic characteristics of the long-lived individuals from the CEPH Aging cohort

Age range (years)	Participants (N) considering their age at inclusion		Participants (N) considering their age at death		Participants (N) considering their age at last known health status
	All (% of women)	Unrelated	All (% of women)	Unrelated	All (% of women)	Unrelated
≥ 90	1712 (75.76)	1411	1454 (76.96)	1207	1746 (75.43)	1412
[90-99] ; nonagenarians	710 (63.10)	487	347 (54.47)	234	481 (54.68)	321
≥100 ; centenarians	1002 (84.73)	996	1107 (84.01)	1063	1265 (83.32)	1212
[100-104]	930 (84.62)	927	874 (82.49)	841	984 (82.22)	944
[105-109] ; semi-supercentenarians	66 (84.85)	66	218 (90.37)	218	256 (87.89)	255
≥110 ; supercentenarians	6 (100)	6	15 (80)	15	25 (80)	25

Table 3 was incorrectly justified and had a typo, which has been corrected.

Table 3.

Quantitative epidemiologic and clinical data available for long-lived individuals from the CEPH Aging cohort

	All		Men		Women
	% of data available	Mean ± SD	% of data available	Mean ± SD	% of data available	Mean ± SD
Anthropometry
Age at inclusion (years)	100	98.9 ± 4.17	100	96.6 ± 4.57	100	99.64 ± 3.73
Height (cm)	55.78	160.06 ± 8.65	61.77	167.94 ± 7.1	53.83	157.11 ± 7.21
Weight (kg)	58.07	54.98 ± 12.75	62.23	65.84 ± 10.68	56.71	51.09 ± 11.08
Cardiovascular parameters
Pulse rate (bpm)	49.94	74.23 ± 8.88	50.34	71.5 ± 8.61	49.81	75.13 ± 8.79
Systolic blood pressure (cm Hg)	58.93	13.65 ± 1.6	58.74	13.57 ± 1.45	58.99	13.67 ± 1.64
Diastolic blood pressure (cm Hg)	58.19	7.63 ± 0.87	58.04	7.66 ± 0.79	58.23	7.62 ± 0.89
Blood test
Total cholesterol (g/L)	13.11	2.07 ± 0.55	13.75	2 ± 0.71	12.9	2.1 ± 0.49
LDL cholesterol (g/L)	4.41	1.21 ± 0.41	3.72	1.1 ± 0.43	4.63	1.23 ± 0.4
HDL cholesterol (g/L)	5.09	0.52 ± 0.19	3.96	0.52 ± 0.28	5.46	0.52 ± 0.16
Blood glucose (g/L)	30.18	1 ± 0.56	31.7	1.07 ± 0.64	29.68	0.97 ± 0.53
Urea (g/L)	20.84	0.49 ± 0.25	20.74	0.5 ± 0.18	20.88	0.49 ± 0.27
Creatinine level (mg/L)	33.56	11.06 ± 3.82	37.06	12.5 ± 3.94	32.42	10.53 ± 3.64
Cognitive function
Folstein test (points)	20.84	19.62 ± 7.46	22.14	22 ± 6.23	20.42	18.78 ± 7.69
SPMSQ (points)	49.26	6.22 ± 3.57	51.28	7.62 ± 3.54	48.60	5.77 ± 3.47

New Table 3:

We have also corrected gene names that were not italicized in the Discussion.

“It allowed the identification of APOE (p < 0.001) and ACE (p < 0.01) as the first genes associated with human longevity in 1994 using a candidate gene approach in a case–control study including 338 centenarians and 410 adults aged 20–70 years [22]. However, while APOE association was largely replicated in many other studies [23, 24], ACE association should be considered as a false positive signal due to genotyping issues [32].” was corrected to “It allowed the identification of APOE (p < 0.001) and ACE (p < 0.01) as the first genes associated with human longevity in 1994 using a candidate gene approach in a case–control study including 338 centenarians and 410 adults aged 20–70 years [22]. However, while APOE association was largely replicated in many other studies [23, 24], ACE association should be considered as a false positive signal due to genotyping issues [32].”